Abstract
• Background: Graves' orbitopathy (GO) is generally considered to have an autoimmune etiology. Recently, however, it has been hypothesized that orbital venous obstruction may contribute significantly to the clinical manifestations. To determine whether such obstruction could induce histologic and clinical findings consistent with GO, we developed an animal model of orbital venous obstruction by ligating the draining ophthalmic veins of the right eyes of four cats.
• Methods: The branches of the ophthalmic veins were isolated and ligated following a lateral orbitotomy. Weekly photographs and echographs were taken of the cats; one cat was killed at each of four time points, namely 1, 2, 3, and 4 weeks after surgery. Histologis stains were applied to isolated orbital tissues to characterize pathologic changes.
• Results: Clinically, there was onset of marked proptosis, chemosis, and exotropia. Histological findings within the extraocular muscles included activation and the presence of acid mucopolysaccharides 1 week after ligation, increased collagen and the presence of lymphoid cells at 2 weeks after ligation, and persistent interstitial lymphocytic infiltrates the 3rd and 4th weeks after ligation.
• Conclusion: Without evoking a primary orbital inflammation or inducing a systemic autoimmune disease, an animal model has been developed that closely mimics many of the advanced clinical and histologic changes that occur in GO.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahmann A, Baker JR jr, Weetman AP, Wartofsky L, Nutman TB, Burman KD (1987) Antibodies to porcine eye muscle in patients with Graves' orbitopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 64: 454–460
Atkinson S, Holcombe M, Kendall-Taylor P (1984) Ophthalmopathic immunoglobulin in patients with Graves' orbitopathy. Lancet 2: 374–376
Bahn RS, Gorman CA, Woloschak GE, David CS, Johnson PM, Johnson CM (1987) Human retroocular fibroblasts in vitro: a model for the study of Graves' orbitopathy. J Clin Endocrinol Metab 65: 665–670
Brooks B (1922) Pathologic changes in muscle as a result of disturbances of circulation: an experimental study of Volkmann's ischemic paralysis. Arch Surg 5: 188–216
Hiromatsu Y, Fukazawa H, How J, Wall JR (1987) Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' orbitopathy —roles of class II MHC antigen expression and γ-interferon action on effector and target cells. Clin Exp Immunol 70: 593–603
Hiromatsu Y, Wang PW, Wosu L, How J, Wall JR (1987) Mechanisms of immune damage in Graves' orbitopathy. Horm Res 26: 198–207
Hiromatsu Y, Fukazawa H, Guinard F, Salvi M, How J, Wall JR (1988) A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated orbitopathy. J Clin Endocrinol Metab 67: 565–570
Hudson HL, Levin L, Feldon SE (1991) Graves exophthalmos unrelated to extraocular muscle enlargement: superior rectus muscle inflammation may induce venous obstruction. Ophthalmology 98: 1495–1499
Hufnagel TJ, Hickey WF, Cobbs WH, Jakobiec FA, Iwamoto T, Eagle RC (1984) Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease. Ophthalmology 91: 1411–1419
Inoue Y, Inoue T, Ichikizaki K, et al. (1978) Computerized orbital tomography in dysthyroid orbitopathy. Jpn J Ophthalmol 22: 286–296
Kodama K, Sikorska H, Bandy-Dafoe P, Bayly R, Wall JR (1982) Demonstrations of a circulating autoantibody against a soluble eye-muscle antigen in Graves' orbitopathy. Lancet 2: 1353–1356
Kroll AJ, Kuwabara T (1966) Dysthyroid ocular myopathy: anatomy, histology, and electron microscopy. Arch Ophthalmol 76: 244–257
Peyster RG, Savino PJ, Hoover ED, Schatz NJ (1984) Differential diagnosis of the enlarged superior ophthalmic vein. J Comput Assist Tomogr 8: 103–107
Prince JH, Diesem CD, Eglitis I, Raskell GL (1960) Anatomy and histology of the eye and orbit in domestic animals. Thomas, Springfield, III, pp 99–127
Riley FC (1972) Orbital pathology in Graves' disease. Mayo Clin Proc 47: 975–979
Rotella CM, Zonefrati R, Toccafondi R, Valente WA, Kohn LD (1986) Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J Clin Endocrinol Metab 62: 357–367
Spierer A, Eisenstein Z (1991) The role of increased intraocular pressure on upgaze in the assessment of Graves ophthalmopathy. Ophthalmology 98: 1491–1494
Tallstedt L, Norberg R (1988) Immunohistochemical staining of normal and Graves' extraocular muscle. Invest Ophthalmol Vis Sci 29: 175–184
Tengroth B (1964) Histological studies of orbital tissues in a case of endocrine exophthalmos before and after remission. Acta Ophthalmol 42: 588–591
Trokel SL, Jakobiec FA (1981) Correlation of CT scanning and pathologic features of ophthalmic Graves' disease. Ophthalmology 88: 553–564
Weetman AP, Cohen S, Gatter KC, Fells P, Shine B (1989) Immunohistochemical analysis of the retrobulbar tissues in Graves' orbitopathy. Clin Exp Immunol 75: 222–227
Wilner HI, Gupta KL, Kelly JK (1980) Orbital pseudotumor: association of orbital vein deformities and myositis. AJNR 1: 305–309
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saber, E., McDonnell, J., Zimmermann, K.M. et al. Extraocular muscle changes in experimental orbital venous stasis: some similarities to graves' orbitopathy. Graefe's Arch Clin Exp Ophthalmol 234, 331–336 (1996). https://doi.org/10.1007/BF00220709
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00220709